{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Mississauga",
      "state": "N/A",
      "country": "Canada",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "92922",
      "recalling_firm": "Contract Pharmaceuticals Limited Canada",
      "address_1": "7600 East Danbro Cres",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA.",
      "recall_number": "D-1139-2023",
      "product_description": "Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60",
      "product_quantity": "11,350 bottles",
      "reason_for_recall": "Defective Container: slow leakage under the cap",
      "recall_initiation_date": "20230823",
      "center_classification_date": "20230829",
      "termination_date": "20250806",
      "report_date": "20230906",
      "code_info": "Lot # 118920, exp. January 2024."
    }
  ]
}